Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats
References (28)
- et al.
Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
Trends Neurosci.
(1990) - et al.
Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia
Mol. Brain Res.
(1995) - et al.
Cell loss and volume reduction in the entorhinal cortex of schizophrenics
Biol. Psychol.
(1988) - et al.
Role of N-methyl-d-aspartate receptors in the induction of synaptic potentiation by burst stimulation patterned after the hippocampal theta rhythm
Brain Res.
(1988) - et al.
A sytematic study of the pharmacological activities of dopamine antagonists
Life Sci.
(1979) - et al.
Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy
Pharmacol. Biochem. Behav.
(1984) - et al.
Glutamate: a new target in schizophrenia?
Trends Pharmacol. Sci.
(1990) - et al.
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Annu Rev. Neurosci.
(1986) - et al.
Phencyclidine-induced psychosis
Am. J. Psychol.
(1978) Is there a neuroanatomic basis for schizophrenia? An old question revisited
Neuroscientist
(1995)
Basal ganglia and limbic system pathology in schizophrenia: a morphometric study of brain volume and shrinkage
Arch. Gen. Psychol.
Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties
Drug Dev. Res.
Dopamine receptor binding predicts clinical and pharmacological potencies of anti schizophrenic drugs
Science
Neuropharmacological studies of phencyclidine (PCP)-induced behavioral stimulation in mice
Psychopharmacology
Cited by (41)
Partial effects of the AMPAkine CX717 in a strain specific battery of tests for manic-like behavior in black Swiss mice
2015, Pharmacological ReportsCitation Excerpt :Control group for each experiment was treated with the same volume of 33% HPCD solution. AMPAkines were repeatedly demonstrated to cross the blood brain barrier after peripheral administration [28] and enter the brain within minutes [44]. To the best of our knowledge, the effects of CX717 on affective-like behavior in animals were not previously reported but the compound was shown to restore primate impaired cognitive performance caused by sleep deprivation [45].
NMDA receptors in the medial prefrontal cortex and the dorsal hippocampus regulate methamphetamine-induced hyperactivity and extracellular amino acid release in mice
2012, Behavioural Brain ResearchCitation Excerpt :Indeed, there are moderate projections between the mPFC and dorsal/ventral hippocampal structure, including the entorhinal cortex, and the mPFC may regulate hippocampal function via the thalamus [69–72]. The present study shows that the MAP-induced increase of Glu release in the mPFC and Glu decrease in the DHC were inhibited by KA or NMDA lesions, which is consistent with other reports [73,74]. Thus, the increased Glu was blocked by NMDA lesion of the DHC after 140 min with MAP, but the KA lesion was still inhibited until the end of this experiment.
Ampakines and the threefold path to cognitive enhancement
2006, Trends in NeurosciencesGlutamate-based therapeutic approaches: Ampakines
2006, Current Opinion in PharmacologyAMPA receptor modulators as cognitive enhancers
2004, Current Opinion in PharmacologySchizophrenia as a disorder of neuroplasticity
2004, International Review of Neurobiology